CliniMACS® CD34 Reagent System

DEVICE2 trials

Sponsors

Weill Medical College of Cornell University

Conditions

Acute Lymphocytic LeukemiaAcute Myelogenous LeukemiaHematologic MalignanciesHodgkin's LymphomaMyelodysplastic SyndromeNon-Hodgkin's Lymphoma

Phase 2

Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies

TerminatedNCT01745913

Weill Medical College of Cornell UniversityAcute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Hodgkin's Lymphoma +2

Start: 2012-10-26End: 2015-04-29Updated: 2018-07-11

Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation

Active, not recruitingNCT01810588

Weill Medical College of Cornell UniversityHematologic Malignancies

Start: 2012-10-16End: 2028-04-30Updated: 2025-09-02

Related Papers

Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning

Blood Advances2019-06-1934 citations